🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the platform has removed violative content and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for preparing or injecting at home.

Within minutes of joining one community, a seller posted WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Details and Pricing

Inside these communities, posts show black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly serious health risks”.